{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,24]],"date-time":"2026-02-24T17:48:17Z","timestamp":1771955297256,"version":"3.50.1"},"reference-count":31,"publisher":"Oxford University Press (OUP)","issue":"2","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":1153,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2012,8]]},"DOI":"10.1111\/j.1365-2133.2012.10964.x","type":"journal-article","created":{"date-parts":[[2012,3,31]],"date-time":"2012-03-31T11:53:40Z","timestamp":1333194820000},"page":"288-295","source":"Crossref","is-referenced-by-count":4,"title":["Topical valrubicin application reduces skin inflammation in murine models"],"prefix":"10.1093","volume":"167","author":[{"given":"E.","family":"Hauge","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.","family":"Christiansen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Rosada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"de Dark\u00f3","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.N.","family":"Dam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.","family":"Stenderup","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2012,7,5]]},"reference":[{"key":"10.1111\/j.1365-2133.2012.10964.x-BIB1|cit1","doi-asserted-by":"crossref","first-page":"69","DOI":"10.2165\/00002512-199915010-00006","article-title":"Valrubicin","volume":"15","author":"Onrust","year":"1999","journal-title":"Drugs Aging"},{"key":"10.1111\/j.1365-2133.2012.10964.x-BIB2|cit2","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/S0090-4295(00)00654-3","article-title":"Pilot study of the tolerability and toxicity of intravesical valrubicin immediately after transurethral resection of superficial bladder cancer","volume":"56","author":"Patterson","year":"2000","journal-title":"Urology"},{"key":"10.1111\/j.1365-2133.2012.10964.x-BIB3|cit3","first-page":"1365","article-title":"N-trifluoroacetyladriamycin-14-valerate, an analog with greater experimental antitumor activity and less toxicity than adriamycin","volume":"35","author":"Israel","year":"1975","journal-title":"Cancer Res"},{"key":"10.1111\/j.1365-2133.2012.10964.x-BIB4|cit4","doi-asserted-by":"crossref","first-page":"2026","DOI":"10.1097\/00005537-200012000-00009","article-title":"Rationale for intralesional valrubicin in chemoradiation of squamous cell carcinoma of the head and neck","volume":"110","author":"Wani","year":"2000","journal-title":"Laryngoscope"},{"key":"10.1111\/j.1365-2133.2012.10964.x-BIB5|cit5","first-page":"261","article-title":"Daunomycin: a cardiotoxic agent","volume":"63","author":"Ainger","year":"1971","journal-title":"J Natl Med Assoc"},{"key":"10.1111\/j.1365-2133.2012.10964.x-BIB6|cit6","first-page":"2572","article-title":"Phase I and preliminary phase II evaluation of adriamycin (NSC 123127)","volume":"30","author":"Bonadonna","year":"1970","journal-title":"Cancer Res"},{"key":"10.1111\/j.1365-2133.2012.10964.x-BIB7|cit7","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1002\/1097-0142(1967)20:3<333::AID-CNCR2820200302>3.0.CO;2-K","article-title":"Daunomycin, an antitumor antibiotic, in the treatment of neoplastic disease. Clinical evaluation with special reference to childhood leukemia","volume":"20","author":"Tan","year":"1967","journal-title":"Cancer"},{"key":"10.1111\/j.1365-2133.2012.10964.x-BIB8|cit8","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1038\/jid.2009.277","article-title":"Valrubicin in a topical formulation treats psoriasis in a xenograft transplantation model","volume":"130","author":"Rosada","year":"2010","journal-title":"J Invest Dermatol"},{"key":"10.1111\/j.1365-2133.2012.10964.x-BIB9|cit9","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1093\/carcin\/bgq122","article-title":"Topical application of valrubicin has a beneficial effect on developing skin tumors","volume":"31","author":"Andersen","year":"2010","journal-title":"Carcinogenesis"},{"key":"10.1111\/j.1365-2133.2012.10964.x-BIB10|cit10","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1093\/carcin\/bgp127","article-title":"Cancer-related inflammation, the seventh hallmark of cancer: links to genetic instability","volume":"30","author":"Colotta","year":"2009","journal-title":"Carcinogenesis"},{"key":"10.1111\/j.1365-2133.2012.10964.x-BIB11|cit11","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1056\/NEJMra0804595","article-title":"Psoriasis","volume":"361","author":"Nestle","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1365-2133.2012.10964.x-BIB12|cit12","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1038\/nature01322","article-title":"Inflammation and cancer","volume":"420","author":"Coussens","year":"2002","journal-title":"Nature"},{"key":"10.1111\/j.1365-2133.2012.10964.x-BIB13|cit13","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1038\/nature07205","article-title":"Cancer-related inflammation","volume":"454","author":"Mantovani","year":"2008","journal-title":"Nature"},{"key":"10.1111\/j.1365-2133.2012.10964.x-BIB14|cit14","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1038\/nri1689","article-title":"Getting under the skin: the immunogenetics of psoriasis","volume":"5","author":"Bowcock","year":"2005","journal-title":"Nat Rev Immunol"},{"key":"10.1111\/j.1365-2133.2012.10964.x-BIB15|cit15","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1007\/s11926-007-0075-1","article-title":"Pathophysiology of psoriasis: recent advances on IL-23 and Th17 cytokines","volume":"9","author":"Fitch","year":"2007","journal-title":"Curr Rheumatol Rep"},{"key":"10.1111\/j.1365-2133.2012.10964.x-BIB16|cit16","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1038\/10552","article-title":"Mice deficient in tumor necrosis factor-alpha are resistant to skin carcinogenesis","volume":"5","author":"Moore","year":"1999","journal-title":"Nat Med"},{"key":"10.1111\/j.1365-2133.2012.10964.x-BIB17|cit17","doi-asserted-by":"crossref","first-page":"10112","DOI":"10.1158\/0008-5472.CAN-10-0775","article-title":"IL-17 enhances tumor development in carcinogen-induced skin cancer","volume":"70","author":"Wang","year":"2010","journal-title":"Cancer Res"},{"key":"10.1111\/j.1365-2133.2012.10964.x-BIB18|cit18","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1038\/sj.jid.5700807","article-title":"Mouse models of psoriasis","volume":"127","author":"Gudjonsson","year":"2007","journal-title":"J Invest Dermatol"},{"key":"10.1111\/j.1365-2133.2012.10964.x-BIB19|cit19","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1159\/000210960","article-title":"Mouse skin inflammation induced by multiple topical applications of 12-O-tetradecanoylphorbol-13-acetate","volume":"4","author":"Stanley","year":"1991","journal-title":"Skin Pharmacol"},{"key":"10.1111\/j.1365-2133.2012.10964.x-BIB20|cit20","doi-asserted-by":"crossref","first-page":"1842","DOI":"10.1016\/S0140-6736(00)04954-0","article-title":"Efficacy and safety of infliximab monotherapy for plaque-type psoriasis: a randomised trial","volume":"357","author":"Chaudhari","year":"2001","journal-title":"Lancet"},{"key":"10.1111\/j.1365-2133.2012.10964.x-BIB21|cit21","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/j.ejca.2006.01.014","article-title":"Inflammation in epithelial skin tumours: old stories and new ideas","volume":"42","author":"Mueller","year":"2006","journal-title":"Eur J Cancer"},{"key":"10.1111\/j.1365-2133.2012.10964.x-BIB22|cit22","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1111\/j.1346-8138.2010.00802.x","article-title":"Positive treatment effects of ustekinumab in psoriasis: analysis of lesional and systemic parameters","volume":"37","author":"Reddy","year":"2010","journal-title":"J Dermatol"},{"key":"10.1111\/j.1365-2133.2012.10964.x-BIB23|cit23","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/BF00684948","article-title":"Pharmacologic rationale for intravesical N-trifluoroacetyladriamycin-14-valerate (AD 32): a preclinical study","volume":"28","author":"Sweatman","year":"1991","journal-title":"Cancer Chemother Pharmacol"},{"key":"10.1111\/j.1365-2133.2012.10964.x-BIB24|cit24","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1146\/annurev-pathol-011811-132448","article-title":"Psoriasis","volume":"7","author":"Perera","year":"2012","journal-title":"Annu Rev Pathol"},{"key":"10.1111\/j.1365-2133.2012.10964.x-BIB25|cit25","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1111\/j.1742-7843.2006.pto_298.x","article-title":"In vivo pharmacological disease models for psoriasis and atopic dermatitis in drug discovery","volume":"99","author":"Petersen","year":"2006","journal-title":"Basic Clin Pharmacol Toxicol"},{"key":"10.1111\/j.1365-2133.2012.10964.x-BIB26|cit26","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1038\/sj.onc.1204076","article-title":"Overexpression of interleukin-6 in human basal cell carcinoma cell lines increases anti-apoptotic activity and tumorigenic potency","volume":"20","author":"Jee","year":"2001","journal-title":"Oncogene"},{"key":"10.1111\/j.1365-2133.2012.10964.x-BIB27|cit27","doi-asserted-by":"crossref","first-page":"5697","DOI":"10.4049\/jimmunol.170.11.5697","article-title":"IL-1 alpha, innate immunity, and skin carcinogenesis: the effect of constitutive expression of IL-1 alpha in epidermis on chemical carcinogenesis","volume":"170","author":"Murphy","year":"2003","journal-title":"J Immunol"},{"key":"10.1111\/j.1365-2133.2012.10964.x-BIB28|cit28","first-page":"445","article-title":"An anti-tumor necrosis factor-alpha antibody inhibits the development of experimental skin tumors","volume":"2","author":"Scott","year":"2003","journal-title":"Mol Cancer Ther"},{"key":"10.1111\/j.1365-2133.2012.10964.x-BIB29|cit29","first-page":"483","article-title":"Interaction of the novel anthracycline antitumor agent N-benzyladriamycin-14-valerate with the C1-regulatory domain of protein kinase C: structural requirements, isoform specificity, and correlation with drug cytotoxicity","volume":"1","author":"Roaten","year":"2002","journal-title":"Mol Cancer Ther"},{"key":"10.1111\/j.1365-2133.2012.10964.x-BIB30|cit30","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1016\/S0022-3565(24)37283-0","article-title":"Pharmacological effects of SB 220025, a selective inhibitor of P38 mitogen-activated protein kinase, in angiogenesis and chronic inflammatory disease models","volume":"284","author":"Jackson","year":"1998","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1111\/j.1365-2133.2012.10964.x-BIB31|cit31","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0898-6568(99)00071-6","article-title":"The p38 signal transduction pathway: activation and function","volume":"12","author":"Ono","year":"2000","journal-title":"Cell Signal"}],"container-title":["British Journal of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2133.2012.10964.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/j.1365-2133.2012.10964.x\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,24]],"date-time":"2025-03-24T17:19:28Z","timestamp":1742836768000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/bjd\/article\/167\/2\/288\/6614059"}},"subtitle":["Topical valrubicin reduces skin inflammation"],"short-title":[],"issued":{"date-parts":[[2012,7,5]]},"references-count":31,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2012,8]]}},"URL":"https:\/\/doi.org\/10.1111\/j.1365-2133.2012.10964.x","relation":{},"ISSN":["0007-0963"],"issn-type":[{"value":"0007-0963","type":"print"}],"subject":[],"published":{"date-parts":[[2012,7,5]]}}}